Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
LabConnect announces the promotion of three executives to top-level management positions.
read more
Tuesday, October 30, 2012
LabConnect, LLC has launched its new service, Scientific Operations Support (SciOps), to offer unique functional outsourcing services to the pharmaceutical research industry.
read more
LabCorp has acquired Sciformix Corporation, a scientific process outsourcing company focused on pharmacovigilance and regulatory solutions for biopharmaceutical and medical devices clients.
read more
Wednesday, November 06, 2019
LabCorp announced John Ratliff is departing the company to pursue another opportunity.
read more
Wednesday, April 13, 2016
Laboratory Corporation of America Holdings® (LabCorp®) has announced that Covance Drug Development has completed an expansion of its now approximately 4,500 square meter (48,000 square foot) central laboratory in Geneva, Switzerland, the largest of ...
read more
Wednesday, April 20, 2022
Labcorp is collaborating with Xcell Biosciences, Inc. to advance critical work that helps clients effectively bring innovative cell and gene therapies to market.
read more
Wednesday, February 20, 2019
LabCorp announced a new assay in its therapeutic drug monitoring (TDM) DoseASSURE portfolio.
read more
Laboratory Corporation of America has announced that Jonathan Zung, Ph.D., has been named group president, Clinical Development & Commercialization Services for Covance Drug Development.
read more
LabCorp has received approval from the FDA for the UltraQual Multiplex PCR Assay for HCV, HIV-1, HIV-2 and HBV for screening of donated blood plasma.
read more
Friday, September 23, 2016
Laboratory Corporation of America® Holdings (LabCorp®) has announced that veteran biopharmaceutical executive John Ratliff will succeed Deborah Keller as CEO of Covance Drug Development, effective October 1. Ratliff will be a member of the LabCorp ...
read more
Tuesday, November 16, 2021
Labcorp opened a new, integrated bioanalytical laboratory in Singapore. The laboratory features new capabilities that enhance the substantial array of bioanalytical services currently offered through Labcorp Drug Development, allowing the company to ...
read more
Friday, December 09, 2022
Labcorp has begun operations at a new, larger anatomic pathology and histology (APH) laboratory in Los Angeles, expanding the company’s global central laboratory capabilities.
read more
Medidata, a Dassault Systèmes company, announced that Labcorp has selected Medidata's technology platform to extend their 14-year partnership, the foundation of their initiative to co-develop digital biomarkers and expand the use and functionality of...
read more
Friday, November 14, 2014
Laboratory Corporation of America® Holdings (LabCorp®) (NYSE: LH) and Covance Inc. (NYSE: CVD) today announced that they have entered into a definitive agreement under which LabCorp will acquire Covance for cash and LabCorp shares currently valued at...
read more
Thursday, November 18, 2021
Labcorp has entered into a definitive agreement to acquire Toxikon, a contract research organization delivering best-in-class nonclinical testing services. Once completed, the transaction will create a strategic footprint for Labcorp to partner with ...
read more